The India wound care management market is expected to register a CAGR of 6.2% over the forecast period.
The spread of COVID-19 rapidly developed into a pandemic, causing serious disruptions to health services, including the care of wounded patients. Due to the need, the delivery of wound care, which should be considered an important medical service, has changed. The main objectives of wound care during this time were to prevent major wound complications to reduce hospitalization and surgery, where possible, rather than eliminate wound healing. Before the pandemic, wound care aims to heal patients' wounds with a combination of smart antibiotics, adequate dressing, and proper loading. As this requires regular visits to the hospital, management's focus has shifted to focus on preventing the development of ulcer problems and hospitalization during COVID-19 times in India according to the article published by Avica Atri, Christian Medical College & Hospital, Vellore, Tamil Nadu India, in 2020
Generally, the wound care management devices market in India is expected to grow due to the increasing incidences of chronic wounds, ulcers, and diabetic ulcers. There is also an increasing prevalence of diabetes, which is the primary cause of diabetic foot ulcers in India.
According to International Diabetes Federation, 2020, there were 77,005,600 number of adults with diabetes in the country, with 8.9% of prevalence in adult population. The survey conducted between 2015 and 2019 by the Rajendra Prasad Center for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi also showed that the prevalence of known diabetes cases was 8.0% and new diabetes cases was 3.8%.Therefore, the increasing number of diabetes patients who are more prone to getting ulcers is expected to boost the market. According to the data published by the World Health Organization, in 2018, India has over 1000,000 people who are being moderately or severely being burnt every year.
The number of diabetic patients is also expected to increase, with the increasing geriatric population, which, in turn, will drive the growth of the wound care management devices market over the forecast period. This can have a major impact, as the recovery period of injuries is delayed among the geriatric population. This will also positively affect the Indian wound care management devices market. Hence, all these factors have been aiding the growth of the wound care management devices market in India.
Recently, due to the COVID-19 pandemic, the number of operations cancelled in India is estimated at 48,728 per week or about 585,000 over 12 weeks, as per a 2020 report published in the British Journal of Surgery. They include elective surgeries, such as bariatric, for severe obesity, and metabolic, for type-2 diabetes. Therefore, these number of surgeries are yet to be performed and after the outbreak of COVID-19, which is expected to boost the market in India.
Key Market Trends
Application in Diabetic Foot Ulcer is Expected to Dominate the Market
Wound dressings represent a part of the management of diabetic foot ulceration. Each category of dressings has particular characteristics that aid selection. All dressings require frequent change for wound inspection. Heavily exudating ulcers like diabetic foot ulcer require a frequent change to reduce maceration of surrounding skin.
The prevalence of diabetic foot ulcer directly relates to the increasing prevalence of diabetes in India. The probability of incidence of diabetic ulcer in a diabetes patient lifetime is very high,
According to 2019, National Diabetes and Diabetic Retinopathy Survey released by the Department of Health and Family Welfare, the prevalence of diabetes was found to be 11.8% in people over the age of 50. The prevalence of diabetes is 6.5% and prediabetes 5.7% among adults under the age of 50, according to a DHS study
Moreover, some reports have suggested that the prevalence of diabetes has increased in India over the past few decades. Therefore with the increasing of the diabetic population, there is an increase in the prevalence of diabetic foot ulcer as well. Hence, this will increase the demand for diabetes foot ulcer wound care management devices, which, in turn, will help the growth of the wound care management devices market in India.
India is a developing country. As result, there is an increasing demand for wound care management devices. This has, in turn, helped in the growth of the wound care management devices market. This has made the market more lucrative. This will encourage the global players to make their presence felt in India. Some of the major players in the country are 3M, Coloplast, Medtronic, and some local players like Centaur Pharma, Axio bioslutions.
Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
This product will be delivered within 2 business days.
Table of Contents
1.2 Scope of the Study
4.2 Market Drivers
4.2.1 Increasing Incidences of Chronic Wounds, Ulcers, and Diabetic Ulcers
4.2.2 Increase in the Volume of Surgical Procedures, and Product Advancements
4.3 Market Restraints
4.3.1 Lack of Awareness Regarding Advanced Wound Care
4.3.2 High Treatment Costs
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5.1.1 Wound Care
188.8.131.52 Other Wound Care Products
5.1.2 Wound Closure
5.2 By Wound Type
5.2.1 Chronic Wound
184.108.40.206 Diabetic Foot Ulcer
220.127.116.11 Pressure Ulcer
18.104.22.168 Other Chronic Wounds
5.2.2 Acute Wound
22.214.171.124 Surgical Wounds
126.96.36.199 Other Acute Wounds
6.1.1 3M Company
6.1.2 B. Braun Melsungen AG
6.1.3 Cardinal Health Inc.
6.1.4 Coloplast A/S
6.1.5 ConvaTec Group PLC
6.1.6 Integra Lifesciences
6.1.7 Medtronic PLC
6.1.8 Molnlycke Health Care
6.1.9 Paul Hartmann AG
6.1.10 Smith & Nephew
6.1.11 Axio Biosolutions
6.1.12 Centaur Pharma
A selection of companies mentioned in this report includes:
- 3M Company
- B. Braun Melsungen AG
- Cardinal Health Inc.
- Coloplast A/S
- ConvaTec Group PLC
- Integra Lifesciences
- Medtronic PLC
- Molnlycke Health Care
- Paul Hartmann AG
- Smith & Nephew
- Axio Biosolutions
- Centaur Pharma